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Abstract
Background: Successful embryonic implantation depends on a synchronized embryo-maternal dialogue.
Chemokines, such as chemokine ligand 1 (CXCL1), play essential roles in the maternal reproductive tract leading
to morphological changes during decidualization, mediating maternal acceptance towards the semi-allograft
embryo and induction of angiogenesis. Chemokine binding to their classical G-protein coupled receptors is
essentially supported by the syndecan (Sdc) family of heparan sulfate proteoglycans. The aim of this study was
to identify the involvement of Sdc-1 at the embryo-maternal interface regarding changes of the chemokine and
angiogenic profile of the decidua during the process of decidualization and implantation in human
endometrium.
Methods: A stable Sdc-1 knock-down was generated in the immortalized human endometrial stromal cell line St-
T1 and was named KdS1. The ability of KdS1 to decidualize was proven by Insulin-like growth factor binding 1
(IGFBP1) and prolactin (PRL) confirmation on mRNA level before further experiments were carried out. Dot blot
protein analyses of decidualized knock-down cells vs non-transfected controls were performed. In order to imitate
embryonic implantation, decidualized KdS1 were then incubated with IL-1beta, an embryo secretion product, vs
controls. Statistical analyses were performed applying the Student’s t-test with p < 0.05, p < 0.02 and p < 0.01 and
one way post-hoc ANOVA test with p < 0.05 as cut-offs for statistical significance.
Results: The induction of the Sdc-1 knock-down revealed significant changes in cytokine and angiogenic factor
expression profiles of dKdS1 vs decidualized controls. Incubation with embryonic IL-1beta altered the expression
patterns of KdS1 chemokines and angiogenic factors towards inflammatory-associated molecules and factors
involved in matrix regulation.
Conclusions: Sdc-1 knock-down in human endometrial stroma cells led to fulminant changes regarding cytokine
and angiogenic factor expression profiles upon decidualization and imitation of embryonic contact. Sdc-1 appears
to play an important role as a co-receptor and storage factor for many cytokines and angiogenic factors during
decidualization and implantation period, supporting proper implantation and angiogenesis by regulation of
chemokine and angiogenic factor secretion in favour of the implanting embryo.
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The successful establishment of a pregnancy in human
depends on a synchronized dialogue of maternal and
embryonic factors enabling attachment of the embryo to
the uterine wall. Invasion into the decidualized maternal
endometrial stroma is followed by induction of angio-
genesis and acceptance of the semi-allograft embryo by
the maternal immune system.
Cytokines are well-characterized factors in the implan-
tation period [1]. Interleukin-1beta (IL-1b) was identified
as a secretion product of human syncytiotrophoblast and
trophoblast in early human pregnancy [2]. Furthermore,
higher levels of IL-1b protein and chemokine ligand 1
(CXCL1) were shown to be expressed in the decidua of
early pregnancy [3]. CXCL1 plays an important role in
mediating the acceptance of the maternal immune sys-
tem towards the semi-allograft embryo by attracting spe-
cialized leukocyte populations, such as uterine natural
killer cells (uNK), granulocytes and macrophages sup-
porting essential modifications regarding implantation
and protection of pregnancy [3,4]. Chemokines belong to
a subfamily of cytokines assigned by the position of con-
served cysteins in their amino acid sequence. They func-
tion as chemoattractants for immunocompetent cells like
leukocytes, which migrate towards the highest concentra-
tion of the chemoattractant, and act via G-protein
coupled, 7 transmembrane-domains containing receptors
on their target cells [5]. Especially CXCL1 was shown to
be involved in early maternal reactions of the decidua-
lized stroma to embryonic secretion products. This was
depicted by a significant upregulation of cxcl1 gene
expression after coincubation with trophoblast condi-
tioned medium in-vitro as well as in a co-culture model
of primary endometrial cells and trophoblast explants
[6,7]. Besides the signalling through the classical G-pro-
tein coupled receptors, the heparan sulfate proteoglycan
syndecans (Sdc) also take part as co-receptors in mediat-
ing chemokine function by enhancing the binding of che-
mokines to their innate receptors [8]. Sdcs are localized
on the cell-surface and in the extracellular matrix. They
consist of an ectodomain containing consensus
sequences for heparan sulfate or chondroitin sulfate
attachment, a single conserved transmembrane domain
and a short cytoplasmic domain. Furthermore, they are
described as multifunctional molecules in human, loca-
lized nearly ubiquitously and involved in wound healing,
tumour growth, immune cell function and angiogenesis
[9,10]. Lately, the mRNA expression of Sdc-1 to -4 in
human endometrium of normal cycling healthy women
was observed with a prominent up regulation of Sdc-1
and -4 in whole tissue secretory phase endometrium
samples [11]. Sdc-1 was also found in uteroplacental
units in human, localized apical in chorionic villi actively
invading maternal decidua, supposedly being involved in
embryo-maternal interaction [12].
We hypothesize that Sdc-1 plays an important role in
the process of human decidualization and implantation
by regulation of chemokine and angiogenic factor secre-
tion of decidualized endometrial stroma cells supporting
a proper embryonic attachment and subsequent implan-
tation. In order to investigate this hypothesis, we gener-
ated a stable and inducible human endometrial stroma
Sdc-1 knock-down cell line (called KdS1) which was
further characterized on protein level by dot blot analy-
sis regarding its cytokine and angiogenic factor expres-
sion profile. Furthermore, we investigated decidualized
KdS1 (dKdS1) vs decidualized endometrial stroma cells
(dSt-T1) after coincubation with the trophoblast secre-
tion product IL-1b to identify Sdc-1’sr o l ea n de x p r e s -
sion profile changes in the process of decidualization
and implantation.
Methods
Cell line and cell culture
The human endometrial stroma cell line St-T1 used in
this study was a generous gift from Professor Brosens
(Imperial College, UK, Great Britain). These cells were
initially isolated from normal proliferative endometrial
tissue during diagnostic laparoscopy, immortalized,
named St-T1 and characterized for functionality and
comparability to primary endometrial stromal cells
before [13,14]. They were maintained in a mixture of ¾
(v/v) DMEM and 1/4 (v/v) MCDB 105, supplemented
with 10% (v/v) charcoal-stripped fetal bovine serum
(FBS), 1× penicillin/streptomycin, 40 μg/ml gentamycin,
5 μg/ml insulin (Sigma-Aldrich, Steelze, Germany), 2
mM L-glutamine, 1 mM non-essential amino acids and
1× sodium pyruvate (all except insulin Biowest, Nuaillé,
France).
Transfection of pcDNA6/TR(c) via electroporation
The TREx(tm)-system with the BLOCK-iT(tm) Inducible
H1 RNAi Entry Vector Kit (Invitrogen, Karlsruhe, Ger-
many) was chosen for stable, tetracycline (Tet) inducible
Sdc-1 knock-down in immortalized St-T1. Therefore the
plasmid pcDNA6/TR(c), coding for the Tet-repressor
(TetR), was transfected first in order to generate a TetR
stable expressing host cell line. One cell clone expressing
high levels of TetR was chosen as host for the inducible
knock-down of Sdc-1 regulating the expression of the
short hairpin (sh) RNA of Sdc-1 in trans (Figure 1). The
circular plasmid pcDNA6/TR(c) was transfected succes-
fully in St-T1 using Nucleofection(r) in a Nucleofector(r)
I (Lonza Cologne AG, Cologne, Germany). 10
6 cells were
transfected per well with 3 μg plasmid DNA in buffer V
(Lonza Cologne AG) using the following programs: T-13,
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Page 2 of 13-23, -24, U-17, -23 and -24. The selection with 5 μg/ml
blasticidin started 48 h after transfection was performed.
Immunocytochemistry for TetR
Transfected cells were tested for succesful nuclear trans-
fection of TetR by immunostaining with mouse anti-TetR
(500 μg/ml) (MoBiTec, Göttingen, Germany). Controls
were stained with non-specific mouse immunoglobulin
(IgG) (200 μg/ml) (Santa Cruz Biotechnologies, Santa
Cruz, CA, USA). Cells were cultured with adequate anti-
biotics on Nunc(tm) Lab-Tek(r) glass chamber slides
(Thermo Scientific Fisher, Langenselbold, Germany), fixed
and permeabilized with cold acetone according to manu-
facturer’s instructions for Vectastain(r) ABC-staining
using an immunoperoxidase procedure (Vector Labora-
tories, Burlingame, CA, USA). Briefly, intracellular activity
of peroxidases was quenched with 0.3% (v/v) H2O2 for 20
min and cells consecutively incubated with blocking
serum for 1 h followed by incubation with 1
st antibody
(1:200 in blocking serum) for 1 h. After incubation with
the matching biotinylated 2
nd antibody, cells were incu-
bated with ABC reagent and staining visualized by incuba-
tion with peroxidase substrate solution (DAB, Vector).
Cells were washed, dehydrated, coverslipped and
photographed with a Leica DC 300F microscope (Leica,
Solms, Germany). The clone with the most intense stain-
ing for TetR was chosen for further transfection (Figure 1).
Design of short hairpin RNAs
In a second step, short hairpin (sh) RNAs for the Sdc-1
knock-down were designed imitating tested transient
silencer (si) RNAs for Sdc-1 (database sequence
NM_002997) [15] using Invitrogen’s RNAi Designer [16]
following the manufacturer’s instructions. The first four
bases of the shRNA sequence are required for directed
cloning in the vector pENTR(tm)/H1/TO (see Table 1).
Cloning of shRNAs of interest in pENTR(tm)/H1/TO and
sequencing
For ligation in the pENTR vector, double-strand (ds) oligo
and vector were mixed in a molar ratio of 50:1 and ligation
performed according to manufacturer’sm a n u a l .P o s i t i v e
clones were analyzed by culturing 10 colonies each, fol-
lowed by plasmid DNA isolation (GeneJET(tm) Plasmid
Miniprep Kit; Fermentas, St. Leon-Rot, Germany) and
sequencing with H1 forward and M13 reverse primers
(Invitrogen) at the biomedical research center of the
Heinrich-Heine University (Düsseldorf, Germany).
Figure 1 N u c l e a rt r a n s f e c t i o no fT e t Ri nS t - T 1 . Representative immunocytochemic staining for nuclear TetR-expression in pcDNA6/TR(c)
transfected St-T1 showing the clone with the most intense staining and negative control with non-specific IgG as small insert.
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pcDNA6/TR© transfected St-T1, selection
Clones identified with correct inserted shRNAs for Sdc-
1 - one from each pair (Table 1) - were transfected into
the TetR expressing host cell line via Nucleofection(r)
with program T-23 as described above. Selection with
200 μg/ml Zeocin(r) and 5 μg/ml Blasticidin started
48 h after Nucleofection(r).
Primers for Polymerase Chain Reaction (PCR)
Sequences for b-actin, insulin-like growth factor binding
protein-1 (IGFBP-1) and prolactin (PRL) mRNAs were
obtained from the GenBank Database of the National
Center for Biotechnology Information (NCBI) of the
National Institutes of Health (NIH, [17]). Primers were
synthesized by Eurofins MWG (Ebersberg, Germany).
To ensure that the product detected resulted from
amplification of cDNA rather than contaminating geno-
mic DNA, primers were designed to cross intron/exon
boundaries. Furthermore, PCR products were sequenced
at the biomedical research center of the Heinrich-Heine
University (BMFZ) (Düsseldorf, Germany) and con-
firmed. The sequences and the sizes of the amplified
fragments are listed in Table 2.
RNA isolation, reverse transcription, PCR and real-time
PCR
Total RNA was isolated from cells applying the single-step
method described by Chomczynski & Sacchi [18] and pro-
cessed as described before [19]. Prior to reverse transcrip-
tion (RT), DNA-free RNA was generated by a
desoxyribonuclease I (DNase I) (Fermentas, St. Leon-Rot,
Germany) digestion [20] as described before [21]. RT reac-
tion was performed using 2 μg RNA according to manu-
facturer’s instruction for High Capacity cDNA archive kit
(Applied Biosystems Inc, Foster City, CA, USA).
In subsequent PCRs, b-actin was used as a housekeep-
ing gene and reactions consisted of 1× DreamTaq(tm)
Green PCR Master Mix (Fermentas), 120 ng cDNA, 0.3
μM forward and reverse primer and dH2O ad 25 μl.
After completion of 35 cycles of 94°C for 1 min, 94°C
f o r3 0s e c ,5 6 ° C( b-actin and IGFBP-1) and 53°C (PRL)
for 45 sec and 72°C for 60 sec, the reaction was termi-
nated at 72°C for 7 min and cooled down to 6°C in a
peqSTAR 96 universal gradient thermocycler (PEQLAB
Biotechnology, Erlangen, Germany). PCR-products were
stored at -20°C until 2% agarose-gel electrophoresis was
carried out in the presence of ethidiumbromide (0.2 μg/
ml). After completion of electrophoresis, the agarose-gel
was analyzed by the GelDoc 1000 system (Bio-Rad
Laboratories, Hercules, CA, USA).
The semi-quantitative PCR (real-time PCR) for PRL
and IGFBP-1 normalized to ß-actin and Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was performed
using the Qiagen QuantiTect SYBR Green PCR kit in a
LightCycler (Roche, Indianapolis, IN, USA) as described
previously [22]. Amplification specificity was verified
using melting curve analysis and 2% agarose gel electro-
phoresis of the PCR products. Primer sequences are
listed in Table 2.
The semi-quantitative PCR for Sdc-1 was performed by
collaborators using TaqMan technology (Applied Biosys-
tems Inc). cDNA corresponding to 50 ng total RNA was
used as a template in the PCR reaction consisting of ABI
MasterMix (Applied Biosystems), and pre-designed Taq-
Man gene expression systems (Applied Biosystems)
according to the manufacturers’ instructions. For detection
of Sdc-1, primer Hs00174579_m1 was used and normal-
ized to the expression of mammalian 18S ribosomal RNA
(rRNA) (Hs99999901_s1, all primers by Applied Biosys-
tems). RT-PCR was performed using the ABI PRISM 7300
Sequence Detection System (Applied Biosystems) by using
the default thermal cycling conditions (10 min at 95°C,
and then 40 cycles of 15 sec at 95°C plus 1 min at 60°C).
Data were analyzed using the comparative Ct (2
-ΔΔCt)
method [23] (3 biological and 2 technical repeats).
Table 1 Design of Sdc-1 shRNAs
No. sequence shRNA (5’3’)( loop sequence) database sequence NM_002997
1 top cac cag gac ttc acc ttt gaa acc cga agg ttt caa agg tga agt cc
bottom aaa agg act tca cct ttg aaa cct tcg ggt ttc aaa ggt gaa gtc ct
874agg act tca cct ttg aaa cc893
2 top cac cag gag gaa ttc tat gcc tga cga atc agg cat aga att cct cc
bottom aaa agg agg aat tct atg cct gat tcg tca ggc ata gaa ttc ctc ct
1162agg agg aat tct atg cct ga1181
3 top cac cgg taa gtt aag taa gtt gac gaa tca act tac tta act tac c
bottom aaa agg taa gtt aag taa gtt gat tcg tca act tac tta act tac c
1749ggt aag tta agt aag ttg a1767
Sequences of shRNAs versus Sdc-1 with siRNA sequences are bolded.
Table 2 PCR and RT-PCR primers
sequences 5’ 3’ size of the amplified
fragment [bp]
b-actin for - cagggtgtgatggtgggaatgg
rev - caggatggcgtgagggagagca
409
IGFBP-1 for - agtttagccaaggcacagga
rev - tatctggcagttggggtctc
204
PRL for - gcttctgtatcatctggtcacg
rev - tgcgtaggcagtggagcag
247
GAPDH for - tgcaccaactgcttagc
rev - acagtcttctgggtggcagtg
131
Primers for amplification with PCR and RT-PCR.
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St-T1
The clone resulting from pair 1 was tested for Tet-
induction according to manufacturers’ instructions from
0 to 1000 ng/ml Tet [0, 1, 50, 100, 500, 1000 ng/ml] for
24 and 48 hours and analyzed by RT-PCR for Sdc-1
mRNA expression. The mRNA expression decreased
about 70% after 48 h with 1000 ng/ml Tet (Figure 2)
(3 biological and 2 technical repeats). Subsequently, for
further investigations an incubation time of 48 h with
1000 ng/ml Tet was used. The resulting clone was
named knock-down Sdc-1 (KdS1).
Subcellular protein fractionation and dot blot analysis for
Sdc-1 expression
In order to examine knock-down of Sdc-1 on cellular
level, KdS1 with and without incubation with Tet were
analyzed for Sdc-1 expression via dot blot analysis after
subcellular protein fractionation (3 biological repeats).
Cells were processed following manufacturer’s instruction
for Subcellular Protein Fractionation Kit (Pierce Biotech-
nology, Rockford, IL, USA). 30 μg protein of each mem-
brane fraction of KdS1 with and without Tet incubation
was applied on methanol pre-treated polyvinylidene
difluoride membranes (Immobilon(tm)-P PVDF Mem-
branes, Millipore Corporation, Schwalbach, Germany).
Human mononuclear cells isolated from peripheral blood
served as control. Membranes were blocked with 5% fat-
free milk powder (Sigma Aldrich), 0.1% Tween(r)20
(Sigma Aldrich) in phosphate-buffered saline (PBS) for 30
min, washed and incubated with mouse anti-human Sdc-1
antibody (1 μg/ml; abcam, Cambridge, UK) for 2 h. Finally,
membranes were incubated with horseradish peroxidase
conjugated ECL(tm) anti-mouse IgG (1 μg/ml; GE Health-
care, Buckinghamshire, UK), signals detected using
RapidStep(tm) ECL Reagent (Calbiochem, Darmstadt,
Germany) and analyzed with an Alpha Imager camera
(Biozym Scientific GmbH, Hessisch Oldendorf, Germany)
and the Alpha Ease FT 6.0.0. program (Alpha Innotech
Corporation, San Leandro, CA, USA) (3 biological and 1
technical repeat).
Decidualization of St-T1 and Tet-induced KdS1
St-T1 endometrial stroma cells (St-T1) are known to
decidualize when treated with cyclic-AMP (0.5 mM) and
progesterone (1 μM) for 72 h [13,14]. Double transfected
and Tet-induced KdS1 cells were decidualized under the
same conditions to investigate possible differences in
their ability to decidualize due to the Sdc-1 knock-down.
Decidualization was verified by carrying out a RT-PCR
for the known decidualization markers IGFBP-1 and PRL.
Investigation of chemokine and angiogenic factor profiles
via dot blot analysis with cell culture supernatant of
decidualized St-T1 and KdS1 with or without IL-1b
incubation
dSt-T1 and dKdS1 (passages 3-6) were tested for
IGFBP1 and PRL mRNA expression as described above.
Cells were then incubated with or without IL-1ß (0.1
ng/ml) for 48 h according to previous investigations
[24]. Cell supernatants were stored and applied to Pro-
teome Profiler(tm) human chemokine and angiogenesis
array kits (R&D Systems, Minneapolis, MN, USA) in
order to identify the molecular changes caused by the
Sdc-1 knock-down in human endometrial stromal cells
(n = 4 each). Assays were performed according to man-
ufacturers’ instructions with 1 ml cell-culture superna-
tant containing 3×10
6 cells per ml. Dot blots were
photographed and analyzed with an Alpha Imager cam-
era (Biozym Scientific GmbH) and the Alpha Ease FT
Figure 2 S d c - 1m R N Ae x p r e s s i o na f t e ri n d u c t i o nw i t hT e t . Fold change of Sdc-1 mRNA after 48 h of induction with different Tet
concentrations [0-1000 ng/ml] in KdS1 cells compared with 18S ribosomal RNA (***p < 0.01).
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Page 5 of 136.0.0. program (Alpha Innotech Corporation) (4 biologi-
cal and 1 technical repeat).
Statistical analysis
To investigate the statistical significance of the protein
expressions, the Student’st - t e s tw i t hp<0 . 0 5 ,p<0 . 0 2
and p < 0.01 and one way post-hoc ANOVA test with p <
0.05 as cut-offs for statistical significance were carried out.
Results
Immunocytochemistry
The nuclear transfection of Tet(R) - coding plasmid
pcDNA6/TR(r) was proven and evaluated via intensity
rating of immunocytochemistry staining by two inde-
pendent investigators (Figure 1). All six clones resulting
from blasticidin selection were tested and the clone
showing the strongest staining intensity for Tet(R) was
selected for further transfection with Sdc1 shRNA.
Tet-induction of Sdc-1 knock-down
The induction of Sdc1-RNAi in KdS1 with different Tet
concentrations (0-1000 ng/ml) was tested for 24 and 48
h and Sdc1-mRNA was measured quantitatively by real-
time PCR. A 70% reduction of Sdc1-mRNA was
detected after incubation with 1000 ng/ml Tet for 48 h
compared to untreated KdS1 (Figure 2). This concentra-
tion was used in the following experiments.
Expression of Sdc-1 on cell membrane of KdS1
Tet-incubated KdS1 cells were tested for the protein
expression of Sdc-1 on cellular surface (KdS1 without Tet
incubation served as controls). Human mononuclear cells
served as positive controls. The expression of Sdc-1 in
membrane compartment declined as shown in Figure 3.
Decidualization
KdS1 cells were incubated with Tet for 48 h prior to 72
h of decidualization protocol and tested for the expres-
sion of common decidualization markers IFGBP1 and
PRL. dSt-T1 served as controls. The mRNA expression
of PRL and IGFBP-1 showed no statistical differences in
dKdS1 versus dSt-T1 (Figure 4).
Dot Blots after decidualization
Dot blot arrays for cytokines (Figure 5A, Table 3) and
angiogenic factors (Figure 5B, Table 4) were performed
after 72 h decidualization of dKdS1 vs. dSt-T1 which
served as controls.
The chemokines CXCL1, CXCL8, IL-6 and macro-
phage migration inhibitory factor (MIF) were secreted at
significantly higher levels in dKdS1. Comparable amounts
of IL-13 were secreted from dKdS1 and dSt-T1.
The expression of several cytokines was restricted only
to dKdS1. Secretion of CCL2, CCL5, CXCL10, CXCL11
and soluble intercellular adhesion molecule (sICAM-1)
occurred in dKdS1 supernatant only. Furthermore, we
detected the peptide hormone granulocyte colony-sti-
mulating factor (G-CSF) and the glycoprotein granulo-
cyte macrophage colony-stimulating factor (GM-CSF),
both involved in immune cell differentiation and infec-
tion mechanisms, only in dKdS1 (Figure 5A).
When investigating angiogenic factors after deciduali-
zation, dKdS1 supernatant contained significantly more
hepatocyte growth factor (HGF, scatter factor), a para-
crine factor which stimulates mitogenesis, angiogenesis
and tumorigenesis, and pentraxin 3 (PTX3), a soluble
molecule which belongs to the innate immune system.
On the other hand, secretion of tissue inhibitor of
metalloproteinases 1 (TIMP-1) and thrombospondin 1
(TSP1), both components of the extracellular matrix,
was significantly increased in dSt-T1.
The secretion levels of the angiogenic factors angio-
poietin-1 (Ang-1), angiogenin, IGFBP-2 and -3, matrix
metalloproteinase 9 (MMP 9) and urokinase-type plas-
minogen activator (uPA) were similar in dKdS1 versus
controls. CXCL16 could be identified to be exclusively
expressed in dKdS1 (Figure 5B). Results are shown in
Table 3 and 4.
Dot Blots after decidualization and IL-1b incubation
Furthermore, dot blot arrays for cytokines (Figure 6A,
Table 3) and angiogenic factors (Figure 6B, Table 4)
were performed after 72 h decidualization followed by
48 h of coincubation with IL-1b imitating early embryo-
nic contact in dKdS1 vs. the control dSt-T1.
Secretion of the cytokine MIF was significantly
increased in dKdS1, whereas CXCL-8 secretion was
higher in dSt-T1 cell culture supernatant. The secretion
levels of CXCL1 and IL-6 were similar in dKdS1 and
dSt-T1 after IL-1ß stimulation. Several cytokines asso-
ciated with inflammatory mechanisms were only
secreted in dKdS1 supernatant, namely G-CSF, GM-
CSF, sICAM-1 and the chemokines CCL2, CCL5,
CXCL10 and CXCL11. IL-13 was secreted in dSt-T1
exclusively (Figure 6A).
Figure 3 Dot blot analysis of Sdc-1 expression in membrane
fraction of KdS1. Protein expression of Sdc-1 before (-) and after
(+) induction with Tet in membrane fraction of KdS1. Mononuclear
cells isolated from peripheral blood served as control (c).
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Page 6 of 13Obvious changes also occurred regarding the expres-
sion profile of angiogenic factors after embryo imitating
IL-1ß contact. HGF and IGFBP-2 were secreted signifi-
cantly higher in dKdS1 compared to dSt-T1. IGFBP-3,
TIMP-1 and TSP1 dominated in dSt-T1 supernatant vs.
dKdS1. There were no statistically significant differences
for MMP9, PTX3 and uPA in dKdS1 vs. dSt-T1. Ang-1
was exclusively secreted from dSt-T1 and angiogenin
and CXCL16 were restricted to dKdS1 (Figure 6B).
Results are shown in Table 3 and 4.
Discussion
The highly synchronized embryonic-maternal dialogue
enables a proper implantation in human. In this study
we have demonstrated an increase in chemokine and
angiogenic factor secretion upon Sdc-1 knock-down in
decidualized human endometrial stroma cells. The
r e s u l t sa r ec o n s i s t e n tw i t ht h er o l eo fS d c - 1a sac o -
receptor and storage factor for these molecules allowing
new insights in interactions and regulations between
chemokines and angiogenic factors contributing to an
improved understanding of intermolecular network at
the embryo-maternal interface. Removal of Sdc-1 from
endometrial stroma cell surfaces by the process of ecto-
domain shedding or down regulation of its expression
leads to a down regulation of binding sites for chemo-
kines and angiogenic factors. Recent studies suggested
that Sdcs and especially Sdc-1 and-4 are involved in
modifying the actions of chemokines and angiogenic
factors by elongation of the ligand-receptor interactions,
storage, establishment of a chemokine concentration
gradient, shedding and regulation of growth-factor
signalling cascades, respectively [9,25]. The recent obser-
vation that newborn Sdc-1 deficient mice are systemi-
cally smaller than their wild-type littermates suggests an
important role for Sdc-1 during embryonic development
[26]. Since animal models can only provide hints
towards the human implantation period, human in-vitro
cell-culture models may be more suitable to mimic the
in-vivo situation of the human species. The immorta-
lized, non-cancerogenous human endometrial stroma
cell line St-T1 was demonstrated to function as an
excellent model for human endometrium before [13,14].
Therefore, this model was used in this study.
The precise molecular actions of Sdc-1 underlying the
morphological and structural changes during the men-
strual cycle in preparation for embryo implantation or
menstrual shedding in absence of fertilization are
unknown until today. This study provides the first evi-
dence of an important contribution of Sdc-1 in regulat-
ing chemokine and growth factor action during the
decidualization and implantation processes.
Selected findings are discussed further in the following
paragraphs.
Chemokines in decidualization and early embryo-
maternal dialogue
The glutamic acid - leucine - arginine (ELR) motif-posi-
tive chemokines CXCL1 and CXCL8 were secreted at
higher levels in the Sdc-1 knock-down cells following
decidualization, as compared to controls. Regarding
secretion after contact with the embryo surrogate, IL-
1ß, CXCL1 expression was comparable in both groups,
whereas CXCL8 increased significantly in dSt-T1
Figure 4 PRL and IGFBP-1 mRNA expression in dKdS1 and dSt-T1. Mean cycle threshold value (Ct) of PRL and IGFBP-1 mRNA expression
compared with actin and GAPDH as internal standards after decidualization of KdS1 (dKdS1) (light grey bars) (dSt-T1 (dark grey bars) served as
controls).
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Page 7 of 13supernatant compared to dKdS1. ELR-positive
CXC-chemokines display angiogenic abilities, whereas
chemokines lacking the ELR-motif are often character-
ized as angiostatic factors [27]. CXCL1 and CXCL8 bind
to CXC-receptor 1 (CXCR1) and CXCR2, respectively
[28,29]. Sdc-1 was shown to interact with CXCL1,
CXCL8 and their receptors via its anionic heparan sul-
fate chain [30,31]. As Sdc-1 might be a storage molecule
for chemokines, and has been shown to establish func-
tional gradients for CXCL1 and CXCL8, the increase in
CXCL1 and CXCL8 secretion in dKdS1 compared to
normal dSt-T1 upon decidualization is most likely due
to the absence of Sdc-1 in dKdS1 cells [30,31]. Further-
more, the rise of CXCL8 after embryo contact in normal
decidualized cells links this molecule to early
angiogenesis. Interestingly, CXCL8 remains low in
dKdS1 after incubation with IL-1ß and nearly equal
amounts of CXCL1 are secreted in dKdS1 and dSt-T1.
This might be a hint for further chemokine intermole-
cular networks or a possible function of Sdc-1 in regu-
lating the CXCL1 and CXCL8 signalling. Recent studies
focused on Sdc-1’s role in promoting tumour invasion
in endometrial cancer cell lines in-vitro via nuclear fac-
tor-kappaB (NF-B) signalling [32]. This signalling cas-
cade was also shown to be involved in CXCL1 signalling
in esophageal cancer and in CXCL8 secretion in primary
human hepatocytes [33,34]. The reduced CXCL8 secre-
tion in dKdS1 cells after IL-1ß contact might be based
on a lack of NF-B signalling or limited CXCL1 and
CXCL8 synthesis in dKdS1.
Figure 5 Pixel density analysis of cytokine (A) and angiogenic factor (B) dot blot array of decidualized dSt-T1 (dark grey bars) and
dKdS1 (light grey bars) (n=4 each) (*p<0.05, **p<0.02, ***p<0.01). A) pixel analysis of secreted chemokines and B) pixel analysis of secreted
angiogenic factors.
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Page 8 of 13C-C motif chemokine ligand 2 (CCL2, formerly mono-
cyte chemotactic protein-1, MCP-1) was described to be
secreted into the uterine lumen as well as in the endo-
metrial stroma by human primary endometrial epithelial
cells and in first trimester decidua tissue functioning as
a key player of monocyte chemotaxis [35,36]. Further-
more, CCL2 and its receptor CCR2 were detected in
human first trimester decidual tissues with CCL2 being
constantly secreted by decidual stromal cells via extra-
cellular signal-regulated kinase (ERK) and mitogen-acti-
vated protein kinase (MAPK) signalling [37]. Since we
detected CCL2 only in dKdS1 supernatant upon decid-
ualization and imitation of embryo contact, we propose
an active role for Sdc-1 in binding of CCL2 in human
decidualized endometrium in-vitro.T h i ss t o r a g eo f
CCL2 by Sdc-1 in dES in-vitro seems to be inconsistent
with the in-vivo situation of early pregnancy described
in the literature [37]. Hence, there might be a temporal
regulation of CCL2 expression as these data reflect the
very early embryo-maternal dialogue. The absence of
CCL2 expression in dES in-vitro m i g h tr e s u l tf r o mt h e
absence of factors that influence the decidua in-vivo.
Two further CXC-motif chemokines - CXCL10 and 11
- were only secreted in dKdS1 with and without IL-1ß
coincubation. The secretion of CXCL10 and 11 might
result from the lack of Sdc-1 in dKdS1 cell membranes.
In dSt-T1, these molecules are supposingly stored at the
cell membrane via Sdc-1 inhibiting early secretion in the
supernatant. Therefore, the secretion of these factors in
the environment might lead to a shift in the early
immune response of the endometrium and a misdir-
ected angiogenesis, respectively.
Another chemokine, macrophage migration inhibitory
factor (MIF), was significantly more secreted in dKdS1
after decidualization as well as after incubation with IL-
1ß compared to controls. MIF binds to G-protein
coupled receptors CXCR2 and CXCR4 and is involved
in monocyte and T-cell chemotaxis as well as in activa-
tion of integrins and calcium influx [38]. In human
endometrium, an increase in MIF expression was found
in the late proliferative phase followed by a decline dur-
ing the window of implantation suggesting different
roles for MIF during the menstrual cycle [39]. In our
opinion, MIF takes part in the endometrial decidualiza-
tion process supported by the presence of MIF in decid-
ualized endometrial cells (dSt-T1) where its secretion
seems to be regulated by Sdc-1. dKdS1 lack this regula-
tion of MIF and therefore MIF is more secreted after
Sdc-1 knock-down. This regulation might also be
initiated by NF-B signalling similar to the findings in
human primary endometrial cells [40].
Angiogenic and growth factors in decidualization and
early embryo-maternal dialogue
The process of endometrial angiogenesis already starts
in the proliferative phase of the human menstrual cycle
and peaks in the secretory phase. A synchronized pat-
tern of angiogenic factors, growth factors and their inhi-
bitors is therefore a critical precondition supporting not
only angiogenesis but also modification of the extracel-
lular matrix, decidualization and re-organization of the
endometrial stroma.
The paracrine and angiogenic active, glycosaminogly-
can-binding hepatocyte growth factor (HGF) was charac-
terized as an essential key player of trophoblast invasion
mediating trophoblast growth and differentiation via the
signal transducers and activators of transcription (STAT3)
signalling pathway after binding to the receptor c-
mesenchymal-epithelial transition factor (c-Met) localized
Table 3 Cytokine profiling
cytokines dSt-T1 dKdS1 dSt-T1+IL-1b dKdS1+IL-1b
CCL2 + +
CCL5 + +
CXCL1 + + + +
CXCL8 + + + +
CXCL10 + +
CXCL11 + +
G-CSF + +
GM-CSF + +
IL-6 + + + +
IL-13 + + +
MIF + + + +
sICAM-1 + +
Overview of cytokines in cell culture supernatant of decidualized endometrial
stroma cells (dSt-T1), decidualized Sdc-1 knock-down endometrial stroma cells
(dKdS1), decidualized endometrial stroma cells coincubated with IL-1b (dSt-T1
+ IL-1ß) and decidualized Sdc-1 knock-down endometrial stroma cells
coincubated with IL-1b (dKdS1 + IL-1ß). + indicates the presence, - the
absence of the respective cytokine in the cell culture supernatant.
Table 4 Angiogenic factor profiling
angiogenic factors dSt-T1 dKdS1 dSt-T1+IL-1b dKdS1+IL-1b
Ang-1 + + +
Angiogenin + + +
CXCL16 + +
HGF + + + +
IGFBP-2 + + + +
IGFBP-3 + + + +
MMP-9 + + + +
PTX3 + + + +
TIMP-1 + + + +
TSP-1 + + + +
uPA + + + +
Overview of angiogenic factors in cell culture supernatant of decidualized
endometrial stroma cells (dSt-T1), decidualized Sdc-1 knock-down endometrial
stroma cells (dKdS1), decidualized endometrial stroma cells coincubated with
IL-1b (dSt-T1 + IL-1ß) and decidualized Sdc-1 knock-down endometrial stroma
cells coincubated with IL-1b (dKdS1 + IL-1ß). + indicates the presence, - the
absence of the respective angiogenic factor in the cell culture supernatant.
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Page 9 of 13on cytotrophoblast [41-43]. Furthermore, HGF takes part
in embryonic mesenchymal-endothelial interactions and
organogenesis as well as in endometrial stromal cell inva-
sion [44,45]. Sdc-1 has been assigned as a HGF co-recep-
tor intensifying HGFs signalling via c-Met [46]. The
significant increase of HGF in dKdS1 supernatant after
decidualization and after IL-1ß contact as seen in this
study, suggests an intense interaction between Sdc-1 and
HGF. It seems that Sdc-1 is important in HGF-binding
and presentation towards its receptor for supporting cell
proliferation and angiogenesis during the implantation
period. Due to Sdc-1 knock-down HGF-depending pro-
cesses might be dysregulated.
Furthermore, we were able to show that the extracel-
lular matrix glycoprotein thrombospondin 1 (TSP1) was
s i g n i f i c a n t l ym o r es e c r e t e db yn o r m a ld e c i d u a l i z e da n d
IL-1b incubated dSt-T1 compared to dKdS1. Previous
studies focussed on its involvement in endometrial vas-
cularization and decidualization mediated by interferon
g. A modified maternal immune response due to a
reduced TSP1 expression of decidual macrophages was
described in women with unexplained recurrent
embryonic miscarriage [47]. Sdc-1 was found to interact
with TSP1 in the formation of stable cellular matrix
contacts via fascin spikes [48]. We suggest that the lack
o fT S P 1s e c r e t i o ni nd K d S 1i sb a s e do nt h ea b s e n c eo f
the known NF-B activation by IL-1b in dKdS1. There-
fore, the absence of TSP1 might lead to angiogenic mal-
formation and dysregulation of the decidualized
endometrium possibly leading to implantation failure.
Figure 6 Pixel density analysis of cytokine (A) and angiogenic factor (B) dot blot array of decidualized dSt-T1 (dark grey bars) and
dKdS1 (light grey bars) followed by an IL-1ß incubation for 48h (n=4 each) (*p<0.05, **p<0.02, ***p<0.01). A) pixel analysis of secreted
chemokines and B) pixel analysis of secreted angiogenic factors.
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Page 10 of 13The progesterone-dominated secretory phase endome-
trium undergoes dramatic changes in matrix reconstruc-
tion and differentiation dep e n d i n go na no r c h e s t r a t e d
pattern of proteases and inhibitors. Matrix metallopro-
teinases (MMPs) play an important role during the
implantation phase regulated by their inhibitors, e.g. tis-
sue inhibitor of metalloproteinase 1 (TIMP1), localized
in embryonic and maternal tissues [49,50]. TIMP1 is the
most secreted factor in dSt-T1 after decidualization and
IL-1b stimulation. The knock-down of Sdc-1 in dKdS1
therefore leads to a dysregulation of the TIMP-1 expres-
sion possibly enabling an unlimited invasion. Former
studies showed an involvement of Sdc-1 in MMP-9 reg-
ulation, a main target of TIMP-1, mediating endometrial
cancer invasion [32]. These conclusions are supported
by a decreased secretion of TIMP-1 in MCF-7 breast
cancer cells overexpressing soluble Sdc-1 ectodomain,
supporting breast cancer invasiveness [51]. A decreased
expression of TIMP-1 might result in a dysbalanced
implantation as similar levels of MMP-9 were shown in
this study possibly leading to an overinvasion since the
restain mechanism via TIMP-1 is disordered.
The secretion of long pentraxin 3 (PTX3) was most
significantly elevated in dKdS1 supernatant upon decid-
ualization. PTX 3 is a factor of the innate immune sys-
tem and is expressed by a huge variety of cells,
including macrophages, endothelial cells, fibroblasts and
monocytes [52]. Recent studies report a distinct role for
PTX3 mediating decidualization and fertilization in mice
[53]. The increase in PTX3 in dKdS1 supernatant upon
decidualization might result from a stronger inflamma-
tory response in dKdS1 as indicated by the elevated
secretion levels of other chemokines, e.g. CXCL8, com-
pared to dSt-T1. Moreover, a possible dysregulation of
components of the extracellular matrix caused by the
Sdc-1 knock-down might activate the PTX3 release in
order to induce apoptosis, as it was reported for human
neutrophils [54].
Infection-associated molecules in decidualization and
early embryo-maternal dialogue
The modulation of the maternal immune system
enabling an embryonic invasion is one of the key pro-
cesses of the early fetal-maternal communication. The
important role of cytokines, like IL-1ß system, influen-
cing decidualization- and implantation-related molecules,
like MMPs, has already been reported [55]. A recent
study examined the components of endometrial secre-
tions aspirated prior to embryo transfer in IVF and ICSI
cycles, revealing the presence of pro-, as well as anti-
inflammatory immuno-associated molecules [56]. The
pro-inflammatory cytokine IL-6 belonged to the main
secretion products. In the present study, IL-6 secretion
significantly increased in dKdS1 after decidualization.
The increase in IL-6 secretion might be due to the lack
of Sdc-1 and displays a potential intermolecular interac-
tion between IL-6 and Sdc-1. These data correlate well
with observations in Sdc-1 deficient mice subjected to
kidney and allergic inflammation where an increase of
IL-6 was observed [57]. Hence, the lack of Sdc-1 might
induce an inflammatory response in dKdS1 upon decid-
ualization. The similar expression of IL-6 in both groups
upon IL-1ß incubation might result from a balancing
effect of other factors that are activated upon IL-1ß con-
tact in dKdS1.
The cytokines granulocyte (G-) and granulocyte-
macrophage (GM-) colony stimulating factors (CSF) are
involved in the implantation period and early fetal
maternal dialogue. The interaction between G-CSF and
heparan sulfate has been shown in human long-term
culture-initiating cells being raised upon a stromal fee-
der layer [58]. Herein, we detected G-CSF as well as
GM-CSF secretion only in dKdS1 with an increase after
IL-1ß incubation which underscores a very likely inter-
action of these colony-stimulating factors with Sdc-1.
Conclusions
The present study therefore underscores the importance
of Sdc-1 as a co-receptor and a storage molecule in the
receptive endometrium supporting a proper biochemical
basis for embryonic implantation. Further investigation
of Sdc-1s role in the process of implantation is needed,
since its synchronous regulation of multiple receptor-
dependent pathways seems to be a pivotal point in
understanding and possibly ameliorating human
implantation.
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